Midodrine is a medication used to treat symptomatic orthostatic hypotension, a condition characterized by a sudden drop in blood pressure upon standing [1]. It is primarily prescribed for individuals whose orthostatic hypotension is not adequately managed by non-pharmacological interventions [2]. The drug works by constricting blood vessels, which helps to raise blood pressure [3].
How does midodrine work to treat low blood pressure?
Midodrine is a prodrug that is converted in the body to its active metabolite, midodrine--amine [3]. This active compound acts as an alpha-1 adrenergic agonist, meaning it stimulates alpha-1 receptors on the smooth muscle cells of blood vessels [3]. Activation of these receptors causes vasoconstriction, narrowing the blood vessels and thereby increasing peripheral vascular resistance [3]. This leads to an elevation in blood pressure, particularly when the body is in an upright position, and helps to alleviate the symptoms of orthostatic hypotension such as dizziness, lightheadedness, and fainting [2][4].
What are the common side effects of midodrine?
Common side effects associated with midodrine use include a feeling of fullness or having to urinate frequently, as well as paresthesias, which are tingling or prickling sensations [5]. Other reported side effects can include supine hypertension (high blood pressure while lying down), headache, flushing, and nasal or stomach discomfort [5]. Patients are advised to monitor their blood pressure, especially when lying down, to avoid this complication [4].
When does midodrine's patent protection end?
Information regarding the specific patent expiration dates for midodrine is available through specialized patent tracking resources. For detailed patent timelines and exclusivity periods, DrugPatentWatch.com provides comprehensive data [6].
What are the alternatives to midodrine for orthostatic hypotension?
Non-pharmacological approaches are typically the first line of treatment for orthostatic hypotension and may include lifestyle modifications such as increasing fluid and salt intake, wearing compression stockings, and adjusting sleeping positions [2]. When these are insufficient, other medications might be considered, although midodrine is a primary pharmacological option. Other drugs that may be used off-label or in specific circumstances include fludrocortisone and droxidopa, which also aim to manage blood pressure regulation [4].
Who manufactures midodrine?
Midodrine is available in the market from various pharmaceutical manufacturers. Companies that produce or have produced midodrine include Mylan Pharmaceuticals, Teva Pharmaceuticals, and Amneal Pharmaceuticals, among others [7].
What clinical trials have been conducted on midodrine?
Numerous clinical trials have investigated the efficacy and safety of midodrine for treating orthostatic hypotension. Studies have evaluated its effectiveness in improving blood pressure readings, reducing symptomatic episodes, and enhancing patients' quality of life [2][4]. These trials have contributed to understanding its therapeutic profile and potential side effects, guiding its use in clinical practice.
How is midodrine prescribed and dosed?
Midodrine is typically prescribed as oral tablets. Dosing usually starts at a low level and is gradually increased based on the patient's response and tolerability, with dosage adjustments made to minimize supine hypertension [2][4]. It is often recommended that the last dose be taken several hours before bedtime to prevent elevated blood pressure during sleep [5].
[1] https://www.ncbi.nlm.nih.gov/books/NBK519490/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182407/
[3] https://www.rxlist.com/midodrine-drug.htm
[4] https://www.mayoclinic.org/diseases-conditions/orthostatic-hypotension/diagnosis-treatment/drc-20352901
[5] https://www.nhs.uk/medicines/midodrine/
[6] https://drugpatentwatch.com/
[7] https://www.drugs.com/imprints.php?action=search&imprint=AMNEAL